Supernus Pharmaceuticals | 营业费用

股票价格

51.65

每天变化

2.28 4.62%

每月一次

0.80%

每年

34.51%

Q1 预测

50.06

金融业

USD

USD 1.42B

现金及等价物

USD 151.37M

USD 43.29M

USD 593.89M

USD 330.63M

USD 31.77M

USD -60.18M

USD 41.9M

674

EPS每股收益

USD -0.8

股本和储备

USD 1.05B

USD 148.81M

债务利息支出

USD 910K

USD 4.53M

USD 400.38M

USD 2.7B

USD -45.12M

USD 252.29M

USD -60.18M

普通股股本

USD 57.12M

USD 39.11

USD -57.95M

USD 192.1M

销售和管理费用

USD 179.68M

USD 107.1M

贸易债权人

USD 108.61M

应收帐款人

USD 171.25M

	营业费用	更改		日
Abbott	USD 9.21B		17M	2025-12
ANI Pharmaceuticals	USD 505.82M		309.62M	2025-09
Aurora Cannabis	CAD 146.03M		27.79M	2025-09
Bristol-Myers Squibb	USD 8.3B		10.25B	2025-12
Canopy Growth	CAD 80.99M		8.64M	2025-09
Corcept Therapeutics	USD 197.42M		29.66M	2025-09
Eisai	JPY 183.69B		1.78B	2025-09
Eli Lilly	USD 10.31B		1.09B	2025-12
Novo Nordisk	DKK 46.76B		3.99B	2025-12
Pacira	USD 166.36M		4.5M	2025-09
Perrigo	USD 949.9M		50.8M	2025-09
Pfizer	USD 12.91B		79.89B	2025-12
Supernus Pharmaceuticals	USD 252.29M		98.98M	2025-09
United Therapeutics	USD 6.59B		6.07B	2025-09
Xeris Pharmaceuticals	USD 67.65M		590K	2025-09

Supernus Pharmaceuticals 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.